Other languages PreveCeutical Medical Inc. Deutsche Boerse AG

Equities

18H

CA74141E1043

Delayed Deutsche Boerse AG Other stock markets 14:45:29 03/05/2024 BST			5-day change	1st Jan Change
0.019 ^EUR	+80.95%		+26.67%	+35.71%

2023	PreveCeutical Medical Inc. Initiates Preparation of Preclinical Study for Its Diseases & Obtains Proof-Of-Concept Dual Gene Therapy Program	CI
2023	PreveCeutical Medical Prepares For Proof of Concept Preclinical Study For Diabetes, Obesity Dual Gene Therapy Program	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PreveCeutical Medical Inc. Initiates Preparation of Preclinical Study for Its Diseases & Obtains Proof-Of-Concept Dual Gene Therapy Program	12-04
PreveCeutical Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-20
PreveCeutical Medical Inc. and Endosane Pharmaceuticals GmbH Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD and Pharmacologically Relevant Doses Following Intranasal CBD Application	18/09/23
PreveCeutical Medical Inc. Showcases Dynamic Evolution in AI Strategy	12/09/23
PreveCeutical Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	25/08/23
PreveCeutical Medical Inc. Files Cyclic Peptides and Uses Thereof in EU and Australia	24/07/23
PreveCeutical Medical Inc. Files Two Family Patents of Sol-Gel Cannabinoid Formulation and Antiviral Use & Cyclic Peptides and Uses Thereof	28/06/23
Preveceutical Medical Inc. Furthering the Progress of Its Patent Family Directed to Sol-Gel	30/05/23
PreveCeutical Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	29/05/23
PreveCeutical Medical Inc. Auditor Raises 'Going Concern' Doubt	30/04/23
PreveCeutical Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	30/04/23
PreveCeutical Medical Inc. Appoints Shawn Sadler as Head of Artificial Intelligence	24/04/23
PreveCeutical Medical Inc. Launches Clinical Artificial Intelligence Division	24/04/23
Preveceutical Medical Inc. Appoints C. Evan Ballantyne to the Board of Directors	21/02/23
PreveCeutical Medical Inc. Signs Sol-Gel License Agreement with Its Subsidiary PreveCeutical Pty Ltd	09/01/23
PreveCeutical Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	25/11/22
Preveceutical Medical Inc. Announces Appointment of Kathleen Rotika to Board of Directors	20/10/22
PreveCeutical Medical Inc. Announces Resignation of Sachin Nanavati as A Member of the Company's Board of Director, Effective September 16, 2022	15/09/22
PreveCeutical Medical Inc. Appoints Mr. Sachin Nanavati to Board of Directors	06/09/22
PreveCeutical Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	25/08/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages PreveCeutical Medical Inc. Deutsche Boerse AG

Equities

18H

CA74141E1043

Other languages

Filters